| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3423702 | Trends in Parasitology | 2007 | 6 Pages |
Abstract
Replacement of the nematode cuticle with a newly synthesized cuticle (a process known as moulting) occurs four times during larval development. Therefore, the key components of this essential developmental process represent attractive targets for new chemotherapeutic strategies. Recent advances in understanding the molecular genetics of nematode moulting should stimulate and facilitate development of novel drugs that target the essential molecules of the moulting cycle. In particular, we argue that further understanding of the moulting degradome and its key peptidase members offers an important opportunity for the development of novel antinematode agents.
Related Topics
Life Sciences
Immunology and Microbiology
Parasitology
Authors
Hannah Craig, R. Elwyn Isaac, Darren R. Brooks,